APPENDICEAL CANCER

Clinical trials for APPENDICEAL CANCER explained in plain language.

Never miss a new study

Get alerted when new APPENDICEAL CANCER trials appear

Sign up with your email to follow new studies for APPENDICEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1 Completed 1

New hope for hard-to-treat cancers: targeted combo shows promise

Disease control Ongoing

This study tests a new drug (JAB-21822) combined with cetuximab in people with advanced colorectal, small intestine, or appendiceal cancers that have a specific KRAS G12C mutation. Participants must have already tried at least one standard treatment. The goal is to see if the com…

Matched conditions: APPENDICEAL CANCER

Phase: PHASE1, PHASE2 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

APPENDICEAL CANCER

Get alerted when new APPENDICEAL CANCER trials appear

New hope for hard-to-treat cancers: targeted combo shows promise